Latest Strategy News

Page 118 of 903
Pro Medicus Limited’s U.S. arm has secured a significant five-year, A$44 million contract to deploy its cloud-based Visage 7 imaging platform with Advanced Radiology Management, marking a strategic expansion in North America.
Ada Torres
Ada Torres
17 Nov 2025
Locksley Resources has partnered with Columbia University to develop cutting-edge, sustainable technologies for rare earth and critical mineral processing in the US, advancing its Mine-to-Market strategy amid growing government support.
Maxwell Dee
Maxwell Dee
17 Nov 2025
Patriot Resources reports significant copper-zinc-lead assay results from its Phase 1 trenching at Kitumba, Zambia, expanding the mineralised footprint fivefold and setting the stage for further exploration.
Maxwell Dee
Maxwell Dee
17 Nov 2025
Island Pharmaceuticals has secured FDA confirmation that its antiviral Galidesivir can proceed under the Animal Rule pathway for Marburg virus, qualifying for a lucrative Priority Review Voucher. This regulatory milestone accelerates the drug’s path to approval and potential government stockpile inclusion.
Victor Sage
Victor Sage
17 Nov 2025
Nexion Group has finalized the sale of its Nexion Networks and Blue Sky Telecom subsidiaries, pivoting its focus towards AI-driven business intelligence through Fuse Forward.
Sophie Babbage
Sophie Babbage
17 Nov 2025
Spacetalk launches its subscription-based Freedom Platform, aiming to transform family safety tech and hit $20-25 million in annual recurring revenue by 2026. The new app connects multiple generations, expanding beyond smartwatches into a broader digital ecosystem.
Sophie Babbage
Sophie Babbage
17 Nov 2025
Cann Group Limited reminds eligible shareholders that its Share Purchase Plan (SPP) closes today, offering new shares at a discount plus free attaching options, pending shareholder approval.
Ada Torres
Ada Torres
17 Nov 2025
Diablo Resources has appointed Matthew Blumberg as a Non-Executive Director and brought on Ellis Martin as its U.S. Media and Investor Communications Advisor, signaling a strategic push into North American markets.
Maxwell Dee
Maxwell Dee
17 Nov 2025
Algorae Pharmaceuticals has launched a Loyalty Options Offer, allowing eligible shareholders to purchase options at a nominal price, aiming to reward loyalty and support future growth funding.
Ada Torres
Ada Torres
17 Nov 2025
HMC Capital has secured an increased and extended revolving debt facility, enhancing its underwriting capacity and supporting strategic growth initiatives, including its energy transition efforts.
Claire Turing
Claire Turing
17 Nov 2025
Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.
Ada Torres
Ada Torres
17 Nov 2025
Race Oncology has announced pivotal new clinical trials for its lead asset RC220, aiming to accelerate regulatory approval in Acute Myeloid Leukemia and tackle resistance in Non-Small Cell Lung Cancer.
Ada Torres
Ada Torres
17 Nov 2025